Tim-1 mediates the activation of hepatic stellate cells and upregulates Th1 and Th2 cytokines, thereby promoting HCC progression, hinting that Tim1 might be an excellent therapeutic target and prognostic marker for HCC patients. The gene discussed is HAVCR1; the disease is hepatocellular carcinoma.